Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Appointed CFO
Quarterly results
CC transcript
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/12/2010 8-K/A Form 8-K - Current report [amend]
05/22/2009 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Valeant Pharmaceuticals International, Descartes Acquisition Corp., Dow Pharmaceutical Sciences, Inc., and Harris Goodman, as Stockholder Representative †"
05/07/2009 8-K/A Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Updated Cash Flow Data"
03/02/2009 8-K/A Form 8-K/A -- Current report [amend]
09/17/2008 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Unaudited pro forma condensed consolidated financial statements"
08/29/2008 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "License and Collaboration Agreement, between Valeant Pharmaceuticals North America and Glaxo Group Limited*"
03/17/2006 8-K/A Financial Statements and Exhibits
11/08/2005 8-K/A Results of Operations and Financial Condition, Financial Statements and Exhibits
03/25/2005 8-K/A Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Departure of Directors or Princip...
02/17/1998 8-K/A Changes in control of registrant

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy